Recommendations for prevention of perinatal transmission of the Human Immunodeficiency Virus in Costa Rica
DOI:
https://doi.org/10.51481/amc.v55i2.794Keywords:
human immunodeficiency virus, HIV, perinatal transmission, pregnancy, antiretroviral, breastfeeding, BCGAbstract
It is known that perinatal transmission of HIV is preventable by taking some general and some specific measures. The key action to achieve this is to identify which pregnant women are HIV infected early in pregnancy. To achieve this goal it is necessary to perform the ELISA HIV test to all pregnant women at their first prenatal visit. Guidelines for prevention of perinatal transmission of HIV were developed to facilitate the implementation of all necessary actions for the prevention of perinatal transmission of HIV in Costa Rica, providing optimal care to the mother and newborn. The key elements of these guidelines include: treatment with 3 antiretrovirals to pregnant women HIV+ from the 12th week of gestation, intravenous zidovudine in labor, cesarean delivery, suspension of breastfeeding and zidovudine prophylaxis to newborn born from 8 hours old. The guidelines also provide recommendations to proceed in special situations related to pregnant woman HIV+ and her child.
Downloads
References
Panel on treatment of HIV-infected pregnant women and prevention of perinatal transmission. Recommendations for
use of antiretroviral drugs in pregnant HIV-1- infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. Disponible en: http://aidsinfo. nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf. Consultado el 05 de Febrero, 2013. 2012: pp 1-235.
González R. Transmisión maternoinfantil del VIH: mecanismos y medidas preventivas. Documento del programa ESTHER. Madrid 2011: pp1-33.
Connor EN, Sperkling RS, Gelber R, Kiselev P, Scott G, O´Sullivan MJ, et al. Reduction of maternal- infant transmission of human immunodeficiency virus type I with zidovudine treatment. N Engl J Med 1994, 331:1173-1180.
The european mode of delivery collaboration. Elective cesarean section versus vaginal delivery in prevention of vertical HIV1 transmission: a randomized clinical trial. Lancet 1999, 353:1035-1039.
The international perinatal HIV group. The mode of delivery and the risk of vertical transmission of HIV-1- a meta-analysis of 15 prospective cohort studies. N Engl J Med 1999; 340:977-987.
American Academy of Pediatrics. Evaluation and treatment of the Human Immunodeficiency Virus-1 exposed infant. Pediatrics 2004; 114:497-505.
Read JS, Newell ML. Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1 (Review). Cochrane Database Syst Rev. 2005; 4: CD005479.
Public Health Agency of Canada. Perinatal HIV transmission in Canada. Disponible en: http://www.phac-aspc.gc.ca/aids-sida/ publication/epi/2010/7-eng.php. Consultado el 5 de febrero, 2013. 2010: pp 1-7.
Taylor GP, Clayden P, Dhar J, Gandhi K, Gilleece Y, Harding K, et al. British HIV Association guidelines for the management of HIV infection in pregnant women 2012. HIV Med 2012; 13 (Suppl. 2): 87-157.
Burdge DR, Money DM, Forbes JC, Samson LM, Steben M. Canadian consensus guidelines for the care of HIV-positive pregnant women: putting recommendations into practice. CMAJ 2003; 168:1683-1688.
World Health Organization. HIV/AIDS Programme.
Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Recommendations for a public health approach. Disponible en: http://whqlibdoc.who.int/ publications/2010/9789241599818_eng.pdf. Consultado el 05 de febrero, 2013. 2010: pp 1-117.
Legardy-Williams JK, Jamieson DJ, Read JS. Prevention of motherto-child transmission of HIV: the role of cesarean delivery. Clin Perinatol 2010; 37: 777-785.
The international perinatal HIV group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1-a meta-analysis of 15 prospective cohort studies. N Engl J Med 1999; 340: 977-987.
The european mode of delivery collaboration. Elective caesareansection versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 1999; 353: 10351039.
Minkoff H, Burns DN, Landesman S, Youchah J, Goedert JJ, Nugent RP, et al. The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. Am J Obstet Gynecol 1995; 173: 585-589.
Jourdain G, Jean-Yves MJY, Le Coeur S, Ngo-Giang-Huong N, Yuthavisuthi P, Limtrakul A, et al. Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand. J Infect Dis 2007; 196: 1629-1636.
Cotter AM, Brookfield KF, Duthely LM, Gonzalez Quintero VH, Potter JE, O'Sullivan MJ. Duration of membrane rupture and risk of perinatal transmission of HIV-1 in the era of combination antiretroviral therapy. Am J Obstet Gynecol 2012; 207:482-487.
Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, Dollfus C, et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS 2008; 22: 289-299.
Nduati R, John G, Mbori-Ngacha D, Richardson B, Overbaugh J, Mwatha A, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 2000; 283: 1167-1174.
Paintsil E, Andiman WA. Care and management of the infant of the HIV-1 infected mother. Semin Perinatol 2007; 31:112-123.
Álvarez AM. Rathore MH. Hot topics in pediatric HIV/AIDS.
Pediatr Ann 2007; 36:423-432.
Downloads
Published
Versions
- 2013-04-23 (2)
- 2013-04-23 (1)
Issue
Section
License
Copyright (c) 2013 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
